These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 29948401)

  • 1. Real-time, intraoperative detection of residual breast cancer in lumpectomy cavity walls using a novel cathepsin-activated fluorescent imaging system.
    Smith BL; Gadd MA; Lanahan CR; Rai U; Tang R; Rice-Stitt T; Merrill AL; Strasfeld DB; Ferrer JM; Brachtel EF; Specht MC
    Breast Cancer Res Treat; 2018 Sep; 171(2):413-420. PubMed ID: 29948401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility Study of a Novel Protease-Activated Fluorescent Imaging System for Real-Time, Intraoperative Detection of Residual Breast Cancer in Breast Conserving Surgery.
    Smith BL; Lanahan CR; Specht MC; Kelly BN; Brown C; Strasfeld DB; Ferrer JM; Rai U; Tang R; Rice-Stitt T; Biernacka A; Brachtel EF; Gadd MA
    Ann Surg Oncol; 2020 Jun; 27(6):1854-1861. PubMed ID: 31898104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of a novel protease-activated fluorescent imaging system for intraoperative detection of residual breast cancer during breast conserving surgery.
    Lanahan CR; Kelly BN; Gadd MA; Specht MC; Brown CL; Hughes KS; Tang R; Rai U; Brachtel EF; Rice-Stitt T; Smith BL
    Breast Cancer Res Treat; 2021 May; 187(1):145-153. PubMed ID: 33611664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should New "No Ink On Tumor" Lumpectomy Margin Guidelines be Applied to Ductal Carcinoma In Situ (DCIS)? A Retrospective Review Using Shaved Cavity Margins.
    Merrill AL; Tang R; Plichta JK; Rai U; Coopey SB; McEvoy MP; Hughes KS; Specht MC; Gadd MA; Smith BL
    Ann Surg Oncol; 2016 Oct; 23(11):3453-3458. PubMed ID: 27207096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implications of New Lumpectomy Margin Guidelines for Breast-Conserving Surgery: Changes in Reexcision Rates and Predicted Rates of Residual Tumor.
    Merrill AL; Coopey SB; Tang R; McEvoy MP; Specht MC; Hughes KS; Gadd MA; Smith BL
    Ann Surg Oncol; 2016 Mar; 23(3):729-34. PubMed ID: 26467458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ductal carcinoma in situ in core biopsies containing invasive breast cancer: correlation with extensive intraductal component and lumpectomy margins.
    Dzierzanowski M; Melville KA; Barnes PJ; MacIntosh RF; Caines JS; Porter GA
    J Surg Oncol; 2005 May; 90(2):71-6. PubMed ID: 15844190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does the volume of ductal carcinoma in situ impact the positive margin rate in patients undergoing breast conservation for invasive breast cancer?
    Martin-Dunlap TM; Cyr AE; Al Mushawah F; Gao F; Margenthaler JA
    J Surg Res; 2013 Sep; 184(1):228-33. PubMed ID: 23688789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role for intraoperative margin assessment in patients undergoing breast-conserving surgery.
    Cabioglu N; Hunt KK; Sahin AA; Kuerer HM; Babiera GV; Singletary SE; Whitman GJ; Ross MI; Ames FC; Feig BW; Buchholz TA; Meric-Bernstam F
    Ann Surg Oncol; 2007 Apr; 14(4):1458-71. PubMed ID: 17260108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-menopausal Status, High Nuclear Grade, Tumor Size >30 mm and Positive Resection Margins Are Predictors of Residual Tumor After Lumpectomy for Ductal Carcinoma In Situ of the Breast.
    Joste M; Mendes V; Tixier S; Palpacuer C; Laviolle B; Leveque J; Ouldamer L
    Anticancer Res; 2015 Jun; 35(6):3471-7. PubMed ID: 26026112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Separate cavity margin sampling at the time of initial breast lumpectomy significantly reduces the need for reexcisions.
    Cao D; Lin C; Woo SH; Vang R; Tsangaris TN; Argani P
    Am J Surg Pathol; 2005 Dec; 29(12):1625-32. PubMed ID: 16327435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraoperative Fluorescence Guidance for Breast Cancer Lumpectomy Surgery.
    Smith BL; Hunt KK; Carr D; Blumencranz PW; Hwang ES; Gadd MA; Stone K; Dyess DL; Dodge D; Valente S; Dekhne N; Clark P; Lee MC; Samiian L; Lesnikoski BA; Clark L; Smith KP; Chang M; Harris DK; Schlossberg B; Ferrer J; Wapnir IL
    NEJM Evid; 2023 Jul; 2(7):EVIDoa2200333. PubMed ID: 38320161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-time intraoperative detection of breast cancer using near-infrared fluorescence imaging and Methylene Blue.
    Tummers QR; Verbeek FP; Schaafsma BE; Boonstra MC; van der Vorst JR; Liefers GJ; van de Velde CJ; Frangioni JV; Vahrmeijer AL
    Eur J Surg Oncol; 2014 Jul; 40(7):850-8. PubMed ID: 24862545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Near-infrared fluorescence (NIRF) imaging in breast-conserving surgery: assessing intraoperative techniques in tissue-simulating breast phantoms.
    Pleijhuis RG; Langhout GC; Helfrich W; Themelis G; Sarantopoulos A; Crane LM; Harlaar NJ; de Jong JS; Ntziachristos V; van Dam GM
    Eur J Surg Oncol; 2011 Jan; 37(1):32-9. PubMed ID: 21106329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of breast lumpectomy margin assessment as a predictor of residual tumor burden in ductal carcinoma in situ of the breast.
    Neuschatz AC; DiPetrillo T; Steinhoff M; Safaii H; Yunes M; Landa M; Chung M; Cady B; Wazer DE
    Cancer; 2002 Apr; 94(7):1917-24. PubMed ID: 11932892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of imprint cytology for assessment of surgical margins in lumpectomy specimens of breast cancer patients.
    Bakhshandeh M; Tutuncuoglu SO; Fischer G; Masood S
    Diagn Cytopathol; 2007 Oct; 35(10):656-9. PubMed ID: 17854083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the systematic circumferential tumor cavity shaving a representative sample for the remaining mammary gland? About 75 cases.
    Bouzaiene H; Triki A; Ghalleb M; Chemlali M; Benzarti Z; Ben Hassouna J; Gammoudi A; Rahal K
    Breast; 2017 Oct; 35():27-31. PubMed ID: 28644994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discordance between pathologic and radiologic tumor size on breast MRI may contribute to increased re-excision rates.
    Vanderwalde LH; Dang CM; Bresee C; Phillips EH
    Am Surg; 2011 Oct; 77(10):1361-3. PubMed ID: 22127089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Close/positive margins after breast-conserving therapy: additional resection or no resection?
    Wood WC
    Breast; 2013 Aug; 22 Suppl 2():S115-7. PubMed ID: 24074771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of intraoperative entire-circumferential frozen section analysis of lumpectomy margins during breast-conserving surgery for breast cancer.
    Osako T; Nishimura R; Nishiyama Y; Okumura Y; Tashima R; Nakano M; Fujisue M; Toyozumi Y; Arima N
    Int J Clin Oncol; 2015 Dec; 20(6):1093-101. PubMed ID: 25855313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resection margins in ultrasound-guided breast-conserving surgery.
    Olsha O; Shemesh D; Carmon M; Sibirsky O; Abu Dalo R; Rivkin L; Ashkenazi I
    Ann Surg Oncol; 2011 Feb; 18(2):447-52. PubMed ID: 20734147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.